Founded in 1988 in Queensbury, N.Y., U.S., AngioDynamics is today a NASDAQ-listed public company. We are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. Our diverse product line includes market-leading radiofrequency ablation and irreversible electroporation resection systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products.AngioDynamics has distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, through the company’s consistent ability to successfully develop and bring to market new technologies and products. AngioDynamics believes it is well poised to continue that trend. Looking into the future, the company plans to bring forth a continuing stream of innovations that greatly improve patient care by providing the highest-quality, best-performing products.

Antares Pharma, Inc., a pharmaceutical company, focuses on self-injection pharmaceutical products and technologies, and topical gel-based products. It offers injection devices, which include Medi-Jector Vision for insulin; Zomajet 2 Vision, Zomajet Vision X, Twin-Jector EZ II, and Tjet for human growth hormone; Vibex pressure assisted auto injector platform that enables a controlled pressure delivery of drugs into the body utilizing a spring power source; and disposable pen injectors, which are needle-based devices designed to deliver multiple injections from multi-dose drug cartridges. Antares Pharma also develops/commercializes Anturol, an oxybutynin ATD (advanced transdermal delivery)gel, which is in Phase III clinical trials for the treatment of overactive bladder; Elestrin, a transdermal estradiol gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause; LibiGel, a transdermal testosterone gel that is in Phase III clinical studies for the treatment of female sexual dysfunction; Nestorone contraceptive formulation products, which has completed Phase II clinical trials; and Ropinerole to treat a central nervous system. Antares Pharma, Inc. markets its products to pharmaceutical companies primarily in the United States and Europe. It has collaborative arrangements and license agreements primarily with Teva Pharmaceutical Industries, Ltd.; BioSante Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Population Council, Ferring Pharmaceuticals BV; Eli Lilly and Company; JCR Pharmaceuticals Co., Ltd.; and Solvay Pharmaceuticals BV, as well as a strategic alliance with Uman Pharma. Antares Pharma, Inc. was formerly known as Medi-Ject Corporation and changed its name to Antares Pharma, Inc. in January 2001. Antares Pharma, Inc. was founded in 1979 and is based in Ewing, New Jersey.

AtriCure, Inc., a medical device company, develops, manufactures, and sells cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac tissue. Its primary product line includes Isolator Synergy Bipolar Radio-Frequency Ablation Clamps for open-heart procedures and minimally invasive procedures; ablation and sensing unit, a compact power generator that delivers bipolar radio-frequency energy; AtriCure switch box, a compact switch box providing the technology needed for the dual pulsing electrodes, and the ability to connect and toggle between multiple RF devices; Isolator multifunctional pen, a disposable RF device enabling surgeons to toggle back and forth between temporary pacing, sensing, stimulation, and ablation; and Coolrail linear ablation device, a disposable linear RF ablation device, which allows physicians to create an expanded cardiac ablation lesion set during minimally invasive procedures. AtriCure also offers cryoablation system, which consists of various reusable and disposable devices, including the Frigitronics CCS-200 product line for cardiac ablation; and Cryo1, a disposable cryothermy ablation probe, as well as AtriClip system, which is designed to exclude the left atrial appendage by implanting the device during open or minimally invasive surgical procedures from the outside of the heart. In addition, it sells enabling technologies, including Lumitip dissector to separate tissues to provide access to key anatomical structures targeted for ablation during general, thoracic, and other surgical procedures; and MicroPace ORLab system, a stimulating, mapping, and recording system enabling physicians to confirm the ablation lines being created are forming electrical barriers or lines of block. AtriCure, Inc. sells its medical devices to hospitals and medical centers in the United States and internationally. AtriCure, Inc. is headquartered in West Chester, Ohio.

Atrion Corporation develops and manufactures ophthalmology, cardiovascular, and fluid delivery devices primarily for medical applications in the United States and internationally. Atrion Corporation manufactures soft contact lens storage and disinfection cases; and the LacriCATH line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. It develops the MPS2 Myocardial Protection System, a proprietary technology delivering fluids and medications to the heart during open-heart surgery; cardiac surgery vacuum relief valves; Retract-O-Tape silicone vessel loops; inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing; and Clean-Cut rotating aortic punch and PerfectCut Aortotomy System, both of which are used in heart bypass surgery. Atrion manufactures various intravenous fluid delivery products comprising medical tubing clamps; swabbable luer valves; and luer syringe check valves and one-way valves. It produces inflation systems and valves used in marine and aviation safety products; one-way and two-way ‘Breather’ valves for use on electronics cases, munitions cases, pressure vessels, transportation container cases, escape slides, and other medical and non-medical applications; and a line of products designed for safe needle and scalpel blade containment, as well as the ACTester product line consisting of instrumentation and associated disposables used to measure the activated clotting time of blood. Atrion Corporation also provides contract manufacturing services for other original equipment manufacturers of medical devices; and owns and maintains a 22-mile high-pressure steel pipeline in north Alabama that is leased to an industrial gas producer that transports gaseous oxygen to its customers. It sells its products through a sales force. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Founded in 1976, Audika banks on the notion that the market for senior citizens' hearing correction is not affected by economic downturns. "Paris, I can't hear you. Let me turn up my Audika." The company operates about 400 hearing correction centers in about 80 French regions, making Audika a leading network of hearing correction centers in France. It also operates some centers in Italy. The hearing-focused company uses the centers to distribute hearing aids and other related accessories such as batteries and ear protection products.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. It operates in three segments: BioScience, Medication Delivery, and Renal. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products; and vaccines. The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs; intravenous nutrition products; infusion pumps; and inhalation anesthetics. It also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease or irreversible kidney failure. It manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes product for hemodialysis, which is conducted in a hospital or clinic. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, clinical and medical research laboratories, and patients at home under physician supervision. Baxter International Inc. was founded in 1931 and is based in Deerfield, Illinois.

Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey. Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company’s BD Medical segment produces medical devices, which are used in healthcare settings. This segment’s product line includes needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes, pen needles, and other drugs used in the treatment of diabetes; prefillable drug delivery devices; surgical blades/scalpels and regional anesthesia needles and trays; critical care monitoring devices; ophthalmic surgical instruments; and sharps disposal containers. Its BD Diagnostics segment provides products for the safe collection and transport of diagnostics specimens, as well as instrument systems and reagents to detect infectious diseases, healthcare- associated infections (HAI), and cancers. Its product line consists of integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems for sexually transmitted diseases and HAIs; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; and plated media. Its BD Biosciences segment produces research and clinical tools that facilitate the study of cells and its components. Its product line comprises fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life sciences research; cell imaging systems; laboratory products for tissue culture and fluid handling; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. Becton serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.

Benco Dental, the largest privately owned, full-service dental distributor in the United States, has remained in the family since 1930—a family that now includes our more than 30,000 customers and 1,200 associates in 40 states. It’s our mission to deliver success smile after smile. We provide more supply and equipment options than any other full-service distributor, an offering enhanced by a comprehensive suite of services, including office design, equipment repair, practice coaching, financing and project management, wealth management and dental-specific technology solutions. These services are supported by over 340 professionally trained sales representatives and 265 factory-trained service technicians.During Benco Dental’s 80-year history, the company has grown from a single-room office in Wilkes-Barre, PA into the nation’s fastest growing dental distributor with 50 regional showroom locations and four distribution centers. In 2010, Benco Dental opened North America’s largest dental equipment showroom as part of a new corporate headquarters. CenterPoint, the 272,000-square-foot facility built to LEED Silver specifications, is home to 25 fully functional operatories and 14 operational digital X-ray units. It also contains a design concept suite, specialty displays, a handpiece cutting exhibit, sterilization models, and a state-of-the-art training and technology center. CenterPoint is the only place where dentists can come to test drive equipment prior to a purchase.

Bioject Medical Technologies Inc., together with its subsidiaries, develops, manufactures, and distributes needle-free injection therapy systems (NFITS) in the United States and internationally. The company’s NFITS work by forcing liquid medication at high speed through a tiny orifice held against the skin. It offers Biojector 2000, a refinement of jet injection technology that enables healthcare professionals to deliver measured variable doses of medication through the skin, either intramuscularly or subcutaneously without a needle; and drug reconstitution system that allows the transfer of diluents to reconstitute powdered medications into liquid form and withdrawal of liquid medication into a syringe without the use of a needle. Bioject Medical Technologies also offers Vitajet, which is composed of two components, a portable injector unit and a disposable syringe; and ZetaJet, a compact and spring-powered injection device intended to deliver vaccines and injectable medications either subcutaneously or intramuscularly. In addition, the company is developing Iject needle-free injection system, a single prefilled disposable injector for self-injection; Jupiter Jet, a pistol-shaped, or streamlined ergonomic gas-powered injection device for patient and professional use; and pre-filled Biojector syringes. It has a strategic alliance with MPI Research. Bioject Medical Technologies Inc. was founded in 1985 and is based in Tualatin, Oregon.

BIOLASE Technology, Inc. was founded in 1984 and is headquartered in Irvine, California. BIOLASE Technology, Inc., a medical technology company, develops, manufactures, and markets lasers and related products and services focused on technologies for applications and procedures in dentistry and medicine. Its principal products are dental laser systems that allow general dentists, periodontists, endodontists, oral surgeons, and other specialists to perform a range of dental procedures, including cosmetic and complex surgical applications. BioLase Technology offers two categories of laser system products comprising Waterlase family of products and Diode family of products. The Waterlase systems use a combination of water and laser to perform dental procedures for cutting soft and hard tissue plus bone. Its Waterlase systems include Waterlase MD and Waterlase C100 All-Tissue Dental Laser systems. The Diode systems use a semiconductor diode laser to perform soft tissue, hygiene, and cosmetic procedures, including teeth whitening, as well as pain management therapy. Its Diode systems consist of the ezlase, iLase, and Diolase 10 systems. BioLase Technology also provides related accessories and disposable products for its laser systems, which include disposable laser tips, flexible fibers, hand pieces, and tooth whitening gel kits. BIOLASE Technology, Inc. sells its products through direct sales force and a network of independent distributors in the United States and internationally. BioLase Technology was formerly known as Societe Endo Technic, SA and changed its name to BIOLASE Technology, Inc. in 1994.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.